Medifast, Inc.

LSE:0K05 Stock Report

Market Cap: US$207.1m

Medifast Future Growth

Future criteria checks 1/6

Medifast's revenue is forecast to decline at 13.4% per annum while its annual earnings are expected to grow at 4.4% per year. EPS is expected to grow by 5% per annum. Return on equity is forecast to be 2.2% in 3 years.

Key information

4.4%

Earnings growth rate

5.0%

EPS growth rate

Personal Products earnings growth7.0%
Revenue growth rate-13.4%
Future return on equity2.2%
Analyst coverage

Low

Last updated05 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0K05 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026509520271
12/31/2025510318232
12/31/2024598027352
9/30/202467473440N/A
6/30/2024770295461N/A
3/31/2024898688591N/A
12/31/20231,07299141148N/A
9/30/20231,218120174189N/A
6/30/20231,373133200214N/A
3/31/20231,530142199215N/A
12/31/20221,599144178195N/A
9/30/20221,639151116135N/A
6/30/20221,6621576896N/A
3/31/20221,6031654073N/A
12/31/20211,5261646095N/A
9/30/20211,41315897122N/A
6/30/20211,271150130147N/A
3/31/20211,097125174184N/A
12/31/2020935103139145N/A
9/30/202084195140145N/A
6/30/202075976118121N/A
3/31/2020726767278N/A
12/31/2019714787484N/A
9/30/2019689747080N/A
6/30/2019638726069N/A
3/31/2019568646776N/A
12/31/2018501565661N/A
9/30/2018433475155N/A
6/30/201837140N/A61N/A
3/31/201833034N/A55N/A
12/31/201730228N/A43N/A
9/30/201728625N/A33N/A
6/30/201727724N/A27N/A
3/31/201727320N/A24N/A
12/31/201627518N/A25N/A
9/30/201627318N/A28N/A
6/30/201627117N/A30N/A
3/31/201627219N/A27N/A
12/31/201527320N/A29N/A
9/30/201527418N/A28N/A
6/30/201527718N/A27N/A
3/31/201527919N/A25N/A
12/31/201428521N/A26N/A
9/30/201426727N/A33N/A
6/30/201428527N/A31N/A
3/31/201430728N/A38N/A
12/31/201332427N/A42N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0K05's forecast earnings growth (4.4% per year) is above the savings rate (2.1%).

Earnings vs Market: 0K05's earnings (4.4% per year) are forecast to grow slower than the UK market (14.7% per year).

High Growth Earnings: 0K05's earnings are forecast to grow, but not significantly.

Revenue vs Market: 0K05's revenue is expected to decline over the next 3 years (-13.4% per year).

High Growth Revenue: 0K05's revenue is forecast to decline over the next 3 years (-13.4% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 0K05's Return on Equity is forecast to be low in 3 years time (2.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y